메뉴 건너뛰기




Volumn 32, Issue SUPPL. 2, 2005, Pages

Imaging in cell-based therapy for neurodegenerative diseases

Author keywords

Cell transplantation; Huntington's disease; Magnetic resonance imaging; Parkinson's disease; Positron emission tomography

Indexed keywords

3 NITROPROPIONIC ACID; 3,4 DIHYDROXYPHENYLACETIC ACID; 4 AMINOBUTYRIC ACID; ALPHA SYNUCLEIN; AMINE OXIDASE (FLAVIN CONTAINING); AMPHETAMINE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; CATECHOL METHYLTRANSFERASE; CILIARY NEUROTROPHIC FACTOR; CONTRAST MEDIUM; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; GLUTAMATE RECEPTOR; HOMOVANILLIC ACID; IMMUNOSUPPRESSIVE AGENT; METHYLPHENIDATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; NEUROPROTECTIVE AGENT; NITRIC OXIDE SYNTHASE; PARKIN; RACLOPRIDE C 11; RADIOISOTOPE; RADIOLIGAND; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; SOMATOSTATIN; TRACER; UBIQUITIN THIOLESTERASE; VIRUS VECTOR;

EID: 29144503167     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-1909-6     Document Type: Article
Times cited : (14)

References (150)
  • 1
    • 0032617868 scopus 로고    scopus 로고
    • Epidemiology of Parkinson's disease
    • Tanner CM, Ben-Shlomo Y. Epidemiology of Parkinson's disease. Adv Neurol 1999;80:153-9
    • (1999) Adv Neurol , vol.80 , pp. 153-159
    • Tanner, C.M.1    Ben-Shlomo, Y.2
  • 2
    • 7444234716 scopus 로고    scopus 로고
    • Economic evidence in Parkinson's disease: A review
    • Lindgren P. Economic evidence in Parkinson's disease: a review. Eur J Health Econ 2004;5 Suppl 1:S63-6
    • (2004) Eur J Health Econ , vol.5 , Issue.1 SUPPL.
    • Lindgren, P.1
  • 5
    • 0036091142 scopus 로고    scopus 로고
    • Occupational and environmental risk factors for Parkinson's disease
    • Lai BC, Marion SA, Teschke K, Tsui JK. Occupational and environmental risk factors for Parkinson's disease. Parkinsonism Relat Disord 2002;8 5:297-309
    • (2002) Parkinsonism Relat Disord , vol.8 , Issue.5 , pp. 297-309
    • Lai, B.C.1    Marion, S.A.2    Teschke, K.3    Tsui, J.K.4
  • 6
    • 0042521076 scopus 로고    scopus 로고
    • The environment and Parkinson's disease: Is the nigrostriatal system preferentially targeted by neurotoxins?
    • Di Monte DA. The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurol 2003;2 9:531-8
    • (2003) Lancet Neurol , vol.2 , Issue.9 , pp. 531-538
    • Di Monte, D.A.1
  • 7
    • 0033695441 scopus 로고    scopus 로고
    • Levodopa motor complications in Parkinson's disease
    • Obeso JA, Olanow CW, Nutt JG. Levodopa motor complications in Parkinson's disease. Trends Neurosci 2000;23 10 Suppl:S2-7
    • (2000) Trends Neurosci , vol.23 , Issue.10 SUPPL.
    • Obeso, J.A.1    Olanow, C.W.2    Nutt, J.G.3
  • 8
    • 0031933258 scopus 로고    scopus 로고
    • An algorithm (decision tree) for the management of Parkinson's disease: Treatment guidelines
    • American Academy of Neurology
    • Olanow CW, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. American Academy of Neurology. Neurology 1998;50 3 Suppl 3:S1-57
    • (1998) Neurology , vol.50 , Issue.3 SUPPL. 3
    • Olanow, C.W.1    Koller, W.C.2
  • 9
    • 0031439442 scopus 로고    scopus 로고
    • Parkinson's disease: Clinical features
    • Quinn NP. Parkinson's disease: clinical features. Baillieres Clin Neurol 1997;6 1:1-13
    • (1997) Baillieres Clin Neurol , vol.6 , Issue.1 , pp. 1-13
    • Quinn, N.P.1
  • 10
    • 7944228088 scopus 로고    scopus 로고
    • Cognitive and behavioral dysfunction in Parkinson's disease: Neurochemical and clinicopathological contributions
    • Zgaljardic DJ, Foldi NS, Borod JC. Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions. J Neural Transm 2004;111 10-1:1287-301
    • (2004) J Neural Transm , vol.111 , Issue.10-11 , pp. 1287-1301
    • Zgaljardic, D.J.1    Foldi, N.S.2    Borod, J.C.3
  • 11
    • 0032937059 scopus 로고    scopus 로고
    • Diagnostic criteria for Parkinson disease
    • Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56 1:33-9
    • (1999) Arch Neurol , vol.56 , Issue.1 , pp. 33-39
    • Gelb, D.J.1    Oliver, E.2    Gilman, S.3
  • 12
    • 0032916601 scopus 로고    scopus 로고
    • Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: A community-based study
    • Aarsland D, Larsen JP, Cummins JL, Laake K. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 1999;56 5:595-601
    • (1999) Arch Neurol , vol.56 , Issue.5 , pp. 595-601
    • Aarsland, D.1    Larsen, J.P.2    Cummins, J.L.3    Laake, K.4
  • 14
    • 3442876461 scopus 로고    scopus 로고
    • Psychiatric aspects of Parkinson's disease - An update
    • Schrag A. Psychiatric aspects of Parkinson's disease - an update. J Neurol 2004;251 7:795-804
    • (2004) J Neurol , vol.251 , Issue.7 , pp. 795-804
    • Schrag, A.1
  • 16
    • 0001509014 scopus 로고
    • Paralisis Agitans: I. Pathologisches anatomie
    • Berlin Heidelberg New York: Springer
    • Lewy F. Paralisis Agitans: I. Pathologisches anatomie. In: Handbuch der neurologie. Berlin Heidelberg New York: Springer; 1912. p. 920-33
    • (1912) Handbuch der Neurologie , pp. 920-933
    • Lewy, F.1
  • 18
    • 0000022434 scopus 로고
    • Occurrence and distribution of catechol amines in brain
    • Bertler A, Rosengren E. Occurrence and distribution of catechol amines in brain. Acta Physiol Scand 1959;47:350-61
    • (1959) Acta Physiol Scand , vol.47 , pp. 350-361
    • Bertler, A.1    Rosengren, E.2
  • 19
    • 34250928307 scopus 로고
    • Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrangungen des extrapyramidalen Systems
    • Ehinger H, Hornykiewicz O. Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrangungen des extrapyramidalen Systems. Klin Wochenschr 1960;38:1236-9
    • (1960) Klin Wochenschr , vol.38 , pp. 1236-1239
    • Ehinger, H.1    Hornykiewicz, O.2
  • 20
    • 0000486903 scopus 로고
    • Catecholaminergic brain stem regulatory systems
    • Baltimore: Waverly Press
    • Bjorklund A, Lindvall O. Catecholaminergic brain stem regulatory systems. In: Handbook of physiology. Baltimore: Waverly Press; 1986. p. 155-235
    • (1986) Handbook of Physiology , pp. 155-235
    • Bjorklund, A.1    Lindvall, O.2
  • 22
    • 0023740954 scopus 로고
    • Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
    • Hirsch E, Graybiel AM, Agid YA. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 1988;334 6180:345-8
    • (1988) Nature , vol.334 , Issue.6180 , pp. 345-348
    • Hirsch, E.1    Graybiel, A.M.2    Agid, Y.A.3
  • 23
    • 0000056069 scopus 로고
    • Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus
    • Hassler R. Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus. J Psychol Neurol 1938;48:387-476
    • (1938) J Psychol Neurol , vol.48 , pp. 387-476
    • Hassler, R.1
  • 24
    • 0025954066 scopus 로고
    • Ageing and Parkinson's disease: Substantia nigra regional selectivity
    • Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114 Pt 5:2283-301
    • (1991) Brain , vol.114 , Issue.5 PART , pp. 2283-2301
    • Fearnley, J.M.1    Lees, A.J.2
  • 25
    • 51249181873 scopus 로고
    • Dopaminergic deficiency is more pronounced in putamen than in nucleus caudatus in Parkinson's disease
    • Nyberg P, Nordberg A, Wester P, Winblad B. Dopaminergic deficiency is more pronounced in putamen than in nucleus caudatus in Parkinson's disease. Neurochem Pathol 1983;1:193-202
    • (1983) Neurochem Pathol , vol.1 , pp. 193-202
    • Nyberg, P.1    Nordberg, A.2    Wester, P.3    Winblad, B.4
  • 26
    • 0023874410 scopus 로고
    • Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications
    • Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988;318 14:876-80
    • (1988) N Engl J Med , vol.318 , Issue.14 , pp. 876-880
    • Kish, S.J.1    Shannak, K.2    Hornykiewicz, O.3
  • 27
    • 0032816549 scopus 로고    scopus 로고
    • The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease
    • Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999;122 Pt 8:1437-48
    • (1999) Brain , vol.122 , Issue.8 PART , pp. 1437-1448
    • Damier, P.1    Hirsch, E.C.2    Agid, Y.3    Graybiel, A.M.4
  • 28
    • 0014208039 scopus 로고
    • Aromatic amino acids and modification of parkinsonism
    • Cotzias J, Van Woert M, Scheffer L. Aromatic amino acids and modification of parkinsonism. N Engl J Med 1967;276:374-9
    • (1967) N Engl J Med , vol.276 , pp. 374-379
    • Cotzias, J.1    Van Woert, M.2    Scheffer, L.3
  • 30
    • 0027725064 scopus 로고
    • Motor response complications and the function of striatal efferent systems
    • Chase TN, Mouradian MM, Engber TM. Motor response complications and the function of striatal efferent systems. Neurology 1993;43 12 Suppl 6:S23-7
    • (1993) Neurology , vol.43 , Issue.12 SUPPL. 6
    • Chase, T.N.1    Mouradian, M.M.2    Engber, T.M.3
  • 31
    • 0033696872 scopus 로고    scopus 로고
    • Continuous dopamine-receptor stimulation in advanced Parkinson's disease
    • Nutt JG, Obeso JA, Stocchi F. Continuous dopamine-receptor stimulation in advanced Parkinson's disease. Trends Neurosci 2000;23 10 Suppl:S109-15
    • (2000) Trends Neurosci , vol.23 , Issue.10 SUPPL.
    • Nutt, J.G.1    Obeso, J.A.2    Stocchi, F.3
  • 32
    • 0034682308 scopus 로고    scopus 로고
    • A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
    • 056 Study Group
    • Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group. N Engl J Med 2000;342 20:1484-91
    • (2000) N Engl J Med , vol.342 , Issue.20 , pp. 1484-1491
    • Rascol, O.1    Brooks, D.J.2    Korczyn, A.D.3    De Deyn, P.P.4    Clarke, C.E.5    Lang, A.E.6
  • 33
    • 0036723589 scopus 로고    scopus 로고
    • Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease
    • Stocchi F, Ruggieri S, Vacca L, Olanow CW. Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease. Brain 2002;125 Pt 9:2058-66
    • (2002) Brain , vol.125 , Issue.9 PART , pp. 2058-2066
    • Stocchi, F.1    Ruggieri, S.2    Vacca, L.3    Olanow, C.W.4
  • 34
    • 0034050670 scopus 로고    scopus 로고
    • The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson's disease
    • Rascol O. The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson's disease. J Neurol 2000;247 Suppl 2:II51-7
    • (2000) J Neurol , vol.247 , Issue.2 SUPPL.
    • Rascol, O.1
  • 35
    • 0035353741 scopus 로고    scopus 로고
    • Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study
    • Del Dotto P, Pavese N, Gambaccini G, Bernardini S, Metman LV, Chase TN, et al. Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study. Mov Disord 2001;16 3:515-20
    • (2001) Mov Disord , vol.16 , Issue.3 , pp. 515-520
    • Del Dotto, P.1    Pavese, N.2    Gambaccini, G.3    Bernardini, S.4    Metman, L.V.5    Chase, T.N.6
  • 36
    • 0025058215 scopus 로고
    • Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease
    • Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990;247 4942:574-7
    • (1990) Science , vol.247 , Issue.4942 , pp. 574-577
    • Lindvall, O.1    Brundin, P.2    Widner, H.3    Rehncrona, S.4    Gustavii, B.5    Frackowiak, R.6
  • 37
    • 21844473567 scopus 로고    scopus 로고
    • Cell therapy in Parkinson's disease
    • Lindvall O, Bjorklund A. Cell therapy in Parkinson's disease. Neurorx 2004;1 4:382-93
    • (2004) Neurorx , vol.1 , Issue.4 , pp. 382-393
    • Lindvall, O.1    Bjorklund, A.2
  • 38
    • 13144259693 scopus 로고    scopus 로고
    • Cell transplantation in Parkinson's disease: How can we make it work?
    • Winkler C, Kirik D, Bjorklund A. Cell transplantation in Parkinson's disease: how can we make it work? Trends Neurosci 2005;28 2:86-92
    • (2005) Trends Neurosci , vol.28 , Issue.2 , pp. 86-92
    • Winkler, C.1    Kirik, D.2    Bjorklund, A.3
  • 39
    • 0033168820 scopus 로고    scopus 로고
    • Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: An argument for neurotrophic supplementation
    • Collier TJ, Sortwell CE, Daley BF. Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: an argument for neurotrophic supplementation. J Neurosci 1999;19 13:5563-73
    • (1999) J Neurosci , vol.19 , Issue.13 , pp. 5563-5573
    • Collier, T.J.1    Sortwell, C.E.2    Daley, B.F.3
  • 40
    • 0035871386 scopus 로고    scopus 로고
    • Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration
    • Kirik D, Winkler C, Bjorklund A. Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. J Neurosci 2001;21 8:2889-96
    • (2001) J Neurosci , vol.21 , Issue.8 , pp. 2889-2896
    • Kirik, D.1    Winkler, C.2    Bjorklund, A.3
  • 41
    • 0035826089 scopus 로고    scopus 로고
    • Transplantation of embryonic dopamine neurons for severe Parkinson's disease
    • Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001;344 10:710-9
    • (2001) N Engl J Med , vol.344 , Issue.10 , pp. 710-719
    • Freed, C.R.1    Greene, P.E.2    Breeze, R.E.3    Tsai, W.Y.4    DuMouchel, W.5    Kao, R.6
  • 42
    • 0042837887 scopus 로고    scopus 로고
    • A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
    • Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003;54 3:403-14
    • (2003) Ann Neurol , vol.54 , Issue.3 , pp. 403-414
    • Olanow, C.W.1    Goetz, C.G.2    Kordower, J.H.3    Stoessl, A.J.4    Sossi, V.5    Brin, M.F.6
  • 44
    • 0027480960 scopus 로고
    • A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
    • The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72 6:971-83
    • (1993) Cell , vol.72 , Issue.6 , pp. 971-983
  • 45
    • 0032190391 scopus 로고    scopus 로고
    • The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): Comparison with huntingtin in rat and human
    • Gutekunst CA, Li SH, Yi H, Ferrante RJ, Li XJ, Hersch SM. The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): comparison with huntingtin in rat and human. J Neurosci 1998;18 19:7674-86
    • (1998) J Neurosci , vol.18 , Issue.19 , pp. 7674-7686
    • Gutekunst, C.A.1    Li, S.H.2    Yi, H.3    Ferrante, R.J.4    Li, X.J.5    Hersch, S.M.6
  • 46
  • 47
    • 0030001072 scopus 로고    scopus 로고
    • Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin
    • U S A
    • Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA, et al. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc Natl Acad Sci U S A 1996;93 10:5037-42
    • (1996) Proc Natl Acad Sci , vol.93 , Issue.10 , pp. 5037-5042
    • Bao, J.1    Sharp, A.H.2    Wagster, M.V.3    Becher, M.4    Schilling, G.5    Ross, C.A.6
  • 48
    • 9444239187 scopus 로고    scopus 로고
    • Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme
    • Kalchman MA, Graham RK, Xia G, Koide HB, Hodgson JG, Graham KC, et al. Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme. J Biol Chem 1996;271 32:19385-94
    • (1996) J Biol Chem , vol.271 , Issue.32 , pp. 19385-19394
    • Kalchman, M.A.1    Graham, R.K.2    Xia, G.3    Koide, H.B.4    Hodgson, J.G.5    Graham, K.C.6
  • 49
    • 0030986659 scopus 로고    scopus 로고
    • HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain
    • Kalchman MA, Koide HB, McCutcheon K, Graham RK, Nichol K, Nishiyama K, et al. HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nat Genet 1997;16 1:44-53
    • (1997) Nat Genet , vol.16 , Issue.1 , pp. 44-53
    • Kalchman, M.A.1    Koide, H.B.2    McCutcheon, K.3    Graham, R.K.4    Nichol, K.5    Nishiyama, K.6
  • 50
    • 0030919567 scopus 로고    scopus 로고
    • Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia
    • Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, et al. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 1997;41 5:646-53
    • (1997) Ann Neurol , vol.41 , Issue.5 , pp. 646-653
    • Browne, S.E.1    Bowling, A.C.2    MacGarvey, U.3    Baik, M.J.4    Berger, S.C.5    Muqit, M.M.6
  • 51
    • 0031044805 scopus 로고    scopus 로고
    • Energy metabolism defects in Huntington's disease and effects of coenzyme Q10
    • Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF. Energy metabolism defects in Huntington's disease and effects of coenzyme Q10. Ann Neurol 1997;41 2:160-5
    • (1997) Ann Neurol , vol.41 , Issue.2 , pp. 160-165
    • Koroshetz, W.J.1    Jenkins, B.G.2    Rosen, B.R.3    Beal, M.F.4
  • 53
    • 0030787762 scopus 로고    scopus 로고
    • Toward understanding the molecular pathology of Huntington's disease
    • Wellington CL, Brinkman RR, O'Kusky JR, Hayden MR. Toward understanding the molecular pathology of Huntington's disease. Brain Pathol 1997;7 3:979-1002
    • (1997) Brain Pathol , vol.7 , Issue.3 , pp. 979-1002
    • Wellington, C.L.1    Brinkman, R.R.2    O'Kusky, J.R.3    Hayden, M.R.4
  • 54
    • 0026928944 scopus 로고
    • New insights into the clinical features, pathogenesis and molecular genetics of Huntington disease
    • Kremer B, Weber B, Hayden MR. New insights into the clinical features, pathogenesis and molecular genetics of Huntington disease. Brain Pathol 1992;2 4:321-35
    • (1992) Brain Pathol , vol.2 , Issue.4 , pp. 321-335
    • Kremer, B.1    Weber, B.2    Hayden, M.R.3
  • 55
    • 0023880409 scopus 로고
    • The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement
    • Thompson PD, Berardelli A, Rothwell JC, Day BL, Dick JP, Benecke R, et al. The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement. Brain 1988;111 Pt 2:223-44
    • (1988) Brain , vol.111 , Issue.2 PART , pp. 223-244
    • Thompson, P.D.1    Berardelli, A.2    Rothwell, J.C.3    Day, B.L.4    Dick, J.P.5    Benecke, R.6
  • 56
    • 0024242568 scopus 로고
    • Language functions in Huntington's disease
    • Podoll K, Caspary P, Lange HW, Noth J. Language functions in Huntington's disease. Brain 1988;111 Pt 6:1475-503
    • (1988) Brain , vol.111 , Issue.6 PART , pp. 1475-1503
    • Podoll, K.1    Caspary, P.2    Lange, H.W.3    Noth, J.4
  • 61
    • 0019524259 scopus 로고
    • Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease
    • Buck SH, Burks TF, Brown MR, Yamamura HI. Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease. Brain Res 1981;209 2:464-9
    • (1981) Brain Res , vol.209 , Issue.2 , pp. 464-469
    • Buck, S.H.1    Burks, T.F.2    Brown, M.R.3    Yamamura, H.I.4
  • 62
    • 0029586383 scopus 로고
    • Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients
    • Richfield EK, Maguire-Zeiss KA, Vonkeman HE, Voorn P. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients. Ann Neurol 1995;38 6:852-61
    • (1995) Ann Neurol , vol.38 , Issue.6 , pp. 852-861
    • Richfield, E.K.1    Maguire-Zeiss, K.A.2    Vonkeman, H.E.3    Voorn, P.4
  • 63
    • 0027380104 scopus 로고
    • Neurochemical substrates of rigidity and chorea in Huntington's disease
    • Storey E, Beal MF. Neurochemical substrates of rigidity and chorea in Huntington's disease. Brain 1993;116 Pt 5:1201-22
    • (1993) Brain , vol.116 , Issue.5 PART , pp. 1201-1222
    • Storey, E.1    Beal, M.F.2
  • 64
    • 0026320986 scopus 로고
    • Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: A combined study using the section-Golgi method and calbindin D28k immunocytochemistry
    • Ferrante RJ, Kowall NW, Richardson EP Jr. Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry. J Neurosci 1991;11 12:3877-87
    • (1991) J Neurosci , vol.11 , Issue.12 , pp. 3877-3887
    • Ferrante, R.J.1    Kowall, N.W.2    Richardson Jr., E.P.3
  • 65
    • 0028799793 scopus 로고
    • Early loss of neostriatal striosome neurons in Huntington's disease
    • Hedreen JC, Folstein SE. Early loss of neostriatal striosome neurons in Huntington's disease. J Neuropathol Exp Neurol 1995;54 1:105-20
    • (1995) J Neuropathol Exp Neurol , vol.54 , Issue.1 , pp. 105-120
    • Hedreen, J.C.1    Folstein, S.E.2
  • 66
    • 0023950143 scopus 로고
    • Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease
    • Beal MF, Mazurek MF, Ellison DW, Swartz KJ, McGarvey U, Bird ED, et al. Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease. Ann Neurol 1988;23 6:562-9
    • (1988) Ann Neurol , vol.23 , Issue.6 , pp. 562-569
    • Beal, M.F.1    Mazurek, M.F.2    Ellison, D.W.3    Swartz, K.J.4    McGarvey, U.5    Bird, E.D.6
  • 68
    • 0025823405 scopus 로고
    • Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues
    • U S A
    • Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci U S A 1991;88 17:7797-801
    • (1991) Proc Natl Acad Sci , vol.88 , Issue.17 , pp. 7797-7801
    • Dawson, T.M.1    Bredt, D.S.2    Fotuhi, M.3    Hwang, P.M.4    Snyder, S.H.5
  • 69
    • 0026570890 scopus 로고
    • Nitric oxide, a novel neuronal messenger
    • Bredt DS, Snyder SH. Nitric oxide, a novel neuronal messenger. Neuron 1992;8 1:3-11
    • (1992) Neuron , vol.8 , Issue.1 , pp. 3-11
    • Bredt, D.S.1    Snyder, S.H.2
  • 70
    • 0027178135 scopus 로고
    • Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures
    • Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 1993;13 6:2651-61
    • (1993) J Neurosci , vol.13 , Issue.6 , pp. 2651-2661
    • Dawson, V.L.1    Dawson, T.M.2    Bartley, D.A.3    Uhl, G.R.4    Snyder, S.H.5
  • 72
    • 0018973928 scopus 로고
    • Neurochemical alterations in Huntington's chorea: A study of post-mortem brain tissue
    • Spokes EG. Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue. Brain 1980;103 1:179-210
    • (1980) Brain , vol.103 , Issue.1 , pp. 179-210
    • Spokes, E.G.1
  • 73
    • 0017288049 scopus 로고
    • Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea
    • McGeer PL, McGeer EG. Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea. J Neurochem 1976;26 1:65-76
    • (1976) J Neurochem , vol.26 , Issue.1 , pp. 65-76
    • McGeer, P.L.1    McGeer, E.G.2
  • 74
    • 0023269358 scopus 로고
    • Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum
    • Kish SJ, Shannak K, Hornykiewicz O. Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum. Ann Neurol 1987;22 3:386-9
    • (1987) Ann Neurol , vol.22 , Issue.3 , pp. 386-389
    • Kish, S.J.1    Shannak, K.2    Hornykiewicz, O.3
  • 75
    • 0030752709 scopus 로고    scopus 로고
    • Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
    • DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997;277 5334:1990-3
    • (1997) Science , vol.277 , Issue.5334 , pp. 1990-1993
    • DiFiglia, M.1    Sapp, E.2    Chase, K.O.3    Davies, S.W.4    Bates, G.P.5    Vonsattel, J.P.6
  • 76
    • 0026609559 scopus 로고
    • Alternative excitotoxic hypotheses
    • Albin RL, Greenamyre JT. Alternative excitotoxic hypotheses. Neurology 1992;42 4:733-8
    • (1992) Neurology , vol.42 , Issue.4 , pp. 733-738
    • Albin, R.L.1    Greenamyre, J.T.2
  • 77
    • 0023873665 scopus 로고
    • Defect in succinate oxidation by isolated muscle mitochondria in a patient with symmetrical lesions in the basal ganglia
    • Martin JJ, Van de Vyver FL, Scholte HR, Roodhooft AM, Ceuterick C, Martin L, et al. Defect in succinate oxidation by isolated muscle mitochondria in a patient with symmetrical lesions in the basal ganglia. J Neurol Sci 1988;84 2-3:189-200
    • (1988) J Neurol Sci , vol.84 , Issue.2-3 , pp. 189-200
    • Martin, J.J.1    Van De Vyver, F.L.2    Scholte, H.R.3    Roodhooft, A.M.4    Ceuterick, C.5    Martin, L.6
  • 78
    • 0029159804 scopus 로고
    • Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency
    • Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequignot E, et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995;11 2:144-9
    • (1995) Nat Genet , vol.11 , Issue.2 , pp. 144-149
    • Bourgeron, T.1    Rustin, P.2    Chretien, D.3    Birch-Machin, M.4    Bourgeois, M.5    Viegas-Pequignot, E.6
  • 79
    • 0029440732 scopus 로고
    • Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid)
    • He F, Zhang S, Qian F, Zhang C. Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid). Neurology 1995;45 12:2178-83
    • (1995) Neurology , vol.45 , Issue.12 , pp. 2178-2183
    • He, F.1    Zhang, S.2    Qian, F.3    Zhang, C.4
  • 80
    • 0031887047 scopus 로고    scopus 로고
    • Safety of intrastriatal neurotransplantation for Huntington's disease patients
    • Kopyov OV, Jacques S, Lieberman A, Duma CM, Eagle KS. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp Neurol 1998;149 1:97-108
    • (1998) Exp Neurol , vol.149 , Issue.1 , pp. 97-108
    • Kopyov, O.V.1    Jacques, S.2    Lieberman, A.3    Duma, C.M.4    Eagle, K.S.5
  • 81
    • 0034627143 scopus 로고    scopus 로고
    • Motor and cognitive improvements in patients with Huntington's disease after neural transplantation
    • Bachoud-Levi AC, Remy P, Nguyen JP, Brugieres P, Lefaucheur JP, Bourdet C, et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 2000;356 9246:1975-9
    • (2000) Lancet , vol.356 , Issue.9246 , pp. 1975-1979
    • Bachoud-Levi, A.C.1    Remy, P.2    Nguyen, J.P.3    Brugieres, P.4    Lefaucheur, J.P.5    Bourdet, C.6
  • 82
    • 5644295321 scopus 로고    scopus 로고
    • Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: Results of a phase I study
    • Bloch J, Bachoud-Levi AC, Deglon N, Lefaucheur JP, Winkel L, Palfi S, et al. Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study. Hum Gene Ther 2004;15 10:968-75
    • (2004) Hum Gene Ther , vol.15 , Issue.10 , pp. 968-975
    • Bloch, J.1    Bachoud-Levi, A.C.2    Deglon, N.3    Lefaucheur, J.P.4    Winkel, L.5    Palfi, S.6
  • 83
    • 0017368491 scopus 로고
    • 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat
    • 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28 5:897-916
    • (1977) J Neurochem , vol.28 , Issue.5 , pp. 897-916
    • Sokoloff, L.1    Reivich, M.2    Kennedy, C.3    Des Rosiers, M.H.4    Patlak, C.S.5    Pettigrew, K.D.6
  • 84
    • 0025818553 scopus 로고
    • Positron emission tomography studies of brain receptors
    • Maziere B, Maziere M. Positron emission tomography studies of brain receptors. Fundam Clin Pharmacol 1991;5 1:61-91
    • (1991) Fundam Clin Pharmacol , vol.5 , Issue.1 , pp. 61-91
    • Maziere, B.1    Maziere, M.2
  • 85
    • 0026773680 scopus 로고
    • Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology
    • Stocklin G. Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology. Eur J Nucl Med 1992;19 7:527-51
    • (1992) Eur J Nucl Med , vol.19 , Issue.7 , pp. 527-551
    • Stocklin, G.1
  • 86
    • 5444262034 scopus 로고    scopus 로고
    • Update on PET radiopharmaceuticals: Life beyond fluorodeoxyglucose
    • Shiue CY, Welch MJ. Update on PET radiopharmaceuticals: life beyond fluorodeoxyglucose. Radiol Clin North Am 2004;42 6:1033-53, viii
    • (2004) Radiol Clin North Am , vol.42 , Issue.6 , pp. 1033-1053
    • Shiue, C.Y.1    Welch, M.J.2
  • 87
    • 20844455452 scopus 로고    scopus 로고
    • Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers
    • Hamill TG, Krause S, Ryan C, Bonnefous C, Govek S, Seiders TJ, et al. Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers. Synapse 2005;56 4:205-16
    • (2005) Synapse , vol.56 , Issue.4 , pp. 205-216
    • Hamill, T.G.1    Krause, S.2    Ryan, C.3    Bonnefous, C.4    Govek, S.5    Seiders, T.J.6
  • 88
    • 0038727935 scopus 로고    scopus 로고
    • PET studies on the function of dopamine in health and Parkinson's disease
    • Brooks DJ. PET studies on the function of dopamine in health and Parkinson's disease. Ann N Y Acad Sci 2003;991:22-35
    • (2003) Ann N Y Acad Sci , vol.991 , pp. 22-35
    • Brooks, D.J.1
  • 89
    • 0033491121 scopus 로고    scopus 로고
    • Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
    • Piccini P, Brooks DJ, Bjorklund A, Gunn RN, Grasby PM, Rimoldi O, et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 1999;2 12:1137-40
    • (1999) Nat Neurosci , vol.2 , Issue.12 , pp. 1137-1140
    • Piccini, P.1    Brooks, D.J.2    Bjorklund, A.3    Gunn, R.N.4    Grasby, P.M.5    Rimoldi, O.6
  • 90
    • 0038249170 scopus 로고    scopus 로고
    • Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
    • Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M, et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 2003;9 5:589-95
    • (2003) Nat Med , vol.9 , Issue.5 , pp. 589-595
    • Gill, S.S.1    Patel, N.K.2    Hotton, G.R.3    O'Sullivan, K.4    McCarter, R.5    Bunnage, M.6
  • 91
    • 0026557644 scopus 로고
    • Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine
    • Rascol O, Sabatini U, Chollet F, Celsis P, Montastruc JL, Marc-Vergnes JP, et al. Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch Neurol 1992;49 2:144-8
    • (1992) Arch Neurol , vol.49 , Issue.2 , pp. 144-148
    • Rascol, O.1    Sabatini, U.2    Chollet, F.3    Celsis, P.4    Montastruc, J.L.5    Marc-Vergnes, J.P.6
  • 93
    • 10344236071 scopus 로고    scopus 로고
    • Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: Implications for dyskinesias
    • de la Fuente-Fernandez R, Sossi V, Huang Z, Furtado S, Lu JQ, Calne DB, et al. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. Brain 2004;127 Pt 12:2747-54
    • (2004) Brain , vol.127 , Issue.12 PART , pp. 2747-2754
    • De La Fuente-Fernandez, R.1    Sossi, V.2    Huang, Z.3    Furtado, S.4    Lu, J.Q.5    Calne, D.B.6
  • 94
    • 0031467450 scopus 로고    scopus 로고
    • Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease
    • Antonini A, Leenders KL, Vontobel P, Maguire RP, Missimer J, Psylla M, et al. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. Brain 1997;120 Pt 12:2187-95
    • (1997) Brain , vol.120 , Issue.12 PART , pp. 2187-2195
    • Antonini, A.1    Leenders, K.L.2    Vontobel, P.3    Maguire, R.P.4    Missimer, J.5    Psylla, M.6
  • 95
    • 20444477480 scopus 로고    scopus 로고
    • Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system
    • Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005;128 Pt 6:1314-22
    • (2005) Brain , vol.128 , Issue.6 PART , pp. 1314-1322
    • Remy, P.1    Doder, M.2    Lees, A.3    Turjanski, N.4    Brooks, D.5
  • 97
    • 0021187087 scopus 로고
    • Reduced striatal glucose consumption and prolonged reaction time are early features in Huntington's disease
    • Garnett ES, Firnau G, Nahmias C, Carbotte R, Bartolucci G. Reduced striatal glucose consumption and prolonged reaction time are early features in Huntington's disease. J Neurol Sci 1984;65 2:231-7
    • (1984) J Neurol Sci , vol.65 , Issue.2 , pp. 231-237
    • Garnett, E.S.1    Firnau, G.2    Nahmias, C.3    Carbotte, R.4    Bartolucci, G.5
  • 98
    • 0027441163 scopus 로고
    • Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease
    • Kuwert T, Lange HW, Boecker H, Titz H, Herzog H, Aulich A, et al. Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease. J Neurol 1993;241 1:31-6
    • (1993) J Neurol , vol.241 , Issue.1 , pp. 31-36
    • Kuwert, T.1    Lange, H.W.2    Boecker, H.3    Titz, H.4    Herzog, H.5    Aulich, A.6
  • 99
    • 0023147905 scopus 로고
    • Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease
    • Mazziotta JC, Phelps ME, Pahl JJ, Huang SC, Baxter LR, Riege WH, et al. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N Engl J Med 1987;316 7:357-62
    • (1987) N Engl J Med , vol.316 , Issue.7 , pp. 357-362
    • Mazziotta, J.C.1    Phelps, M.E.2    Pahl, J.J.3    Huang, S.C.4    Baxter, L.R.5    Riege, W.H.6
  • 100
    • 8644231592 scopus 로고    scopus 로고
    • Neuroimaging trials of Parkinson's disease progression
    • Seibyl J, Jennings D, Tabamo R, Marek K. Neuroimaging trials of Parkinson's disease progression. J Neurol 2004;251 Suppl 7:vII9-13
    • (2004) J Neurol , vol.251 , Issue.7 SUPPL.
    • Seibyl, J.1    Jennings, D.2    Tabamo, R.3    Marek, K.4
  • 101
    • 0037785449 scopus 로고    scopus 로고
    • Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study
    • Whone AL, Watts RL, Stoessl AJ, Davis M, Reske S, Nahmias C, et al. Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL-PET study. Ann Neurol 2003;54 1:93-101
    • (2003) Ann Neurol , vol.54 , Issue.1 , pp. 93-101
    • Whone, A.L.1    Watts, R.L.2    Stoessl, A.J.3    Davis, M.4    Reske, S.5    Nahmias, C.6
  • 102
    • 0028911848 scopus 로고
    • Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease
    • Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJ, Mufson EJ, Sanberg PR, et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 1995;332 17:1118-24
    • (1995) N Engl J Med , vol.332 , Issue.17 , pp. 1118-1124
    • Kordower, J.H.1    Freeman, T.B.2    Snow, B.J.3    Vingerhoets, F.J.4    Mufson, E.J.5    Sanberg, P.R.6
  • 103
    • 21944436225 scopus 로고    scopus 로고
    • Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease
    • Mendez I, Sanchez-Pernaute R, Cooper O, Vinuela A, Ferrari D, Bjorklund L, et al. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 2005;128 Pt 7:1498-510
    • (2005) Brain , vol.128 , Issue.7 PART , pp. 1498-1510
    • Mendez, I.1    Sanchez-Pernaute, R.2    Cooper, O.3    Vinuela, A.4    Ferrari, D.5    Bjorklund, L.6
  • 104
    • 0030834093 scopus 로고    scopus 로고
    • Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease
    • Wenning GK, Odin P, Morrish P, Rehncrona S, Widner H, Brundin P, et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 1997;42 1:95-107
    • (1997) Ann Neurol , vol.42 , Issue.1 , pp. 95-107
    • Wenning, G.K.1    Odin, P.2    Morrish, P.3    Rehncrona, S.4    Widner, H.5    Brundin, P.6
  • 105
    • 7144254462 scopus 로고    scopus 로고
    • Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients
    • Levivier M, Dethy S, Rodesch F, Peschanski M, Vandesteene A, David P, et al. Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients. Stereotact Funct Neurosurg 1997;69 1-4 Pt 2:99-111
    • (1997) Stereotact Funct Neurosurg , vol.69 , Issue.1-4 PART 2 , pp. 99-111
    • Levivier, M.1    Dethy, S.2    Rodesch, F.3    Peschanski, M.4    Vandesteene, A.5    David, P.6
  • 106
    • 0036830588 scopus 로고    scopus 로고
    • Dyskinesia after fetal cell transplantation for parkinsonism: A PET study
    • Ma Y, Feigin A, Dhawan V, Fukuda M, Shi Q, Greene P, et al. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann Neurol 2002;52 5:628-34
    • (2002) Ann Neurol , vol.52 , Issue.5 , pp. 628-634
    • Ma, Y.1    Feigin, A.2    Dhawan, V.3    Fukuda, M.4    Shi, Q.5    Greene, P.6
  • 107
    • 10744219751 scopus 로고    scopus 로고
    • Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue
    • Cochen V, Ribeiro MJ, Nguyen JP, Gurruchaga JM, Villafane G, Loc'h C, et al. Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue. Mov Disord 2003;18 8:928-32
    • (2003) Mov Disord , vol.18 , Issue.8 , pp. 928-932
    • Cochen, V.1    Ribeiro, M.J.2    Nguyen, J.P.3    Gurruchaga, J.M.4    Villafane, G.5    Loc'h, C.6
  • 108
    • 0033767269 scopus 로고    scopus 로고
    • Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts
    • Piccini P, Lindvall O, Bjorklund A, Brundin P, Hagell P, Ceravolo R, et al. Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol 2000;48 5:689-95
    • (2000) Ann Neurol , vol.48 , Issue.5 , pp. 689-695
    • Piccini, P.1    Lindvall, O.2    Bjorklund, A.3    Brundin, P.4    Hagell, P.5    Ceravolo, R.6
  • 109
    • 9144221004 scopus 로고    scopus 로고
    • Striatal neural grafting improves cortical metabolism in Huntington's disease patients
    • Gaura V, Bachoud-Levi AC, Ribeiro MJ, Nguyen JP, Frouin V, Baudic S, et al. Striatal neural grafting improves cortical metabolism in Huntington's disease patients. Brain 2004;127 Pt 1:65-72
    • (2004) Brain , vol.127 , Issue.1 PART , pp. 65-72
    • Gaura, V.1    Bachoud-Levi, A.C.2    Ribeiro, M.J.3    Nguyen, J.P.4    Frouin, V.5    Baudic, S.6
  • 110
    • 0345415042 scopus 로고    scopus 로고
    • In vivo tracing of major rat brain pathways using manganese-enhanced magnetic resonance imaging and three-dimensional digital atlasing
    • Leergaard TB, Bjaalie JG, Devor A, Wald LL, Dale AM. In vivo tracing of major rat brain pathways using manganese-enhanced magnetic resonance imaging and three-dimensional digital atlasing. NeuroImage 2003;20 3:1591-600
    • (2003) NeuroImage , vol.20 , Issue.3 , pp. 1591-1600
    • Leergaard, T.B.1    Bjaalie, J.G.2    Devor, A.3    Wald, L.L.4    Dale, A.M.5
  • 111
    • 0027450301 scopus 로고
    • Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types
    • Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13 3:981-9
    • (1993) J Neurosci , vol.13 , Issue.3 , pp. 981-989
    • Urenjak, J.1    Williams, S.R.2    Gadian, D.G.3    Noble, M.4
  • 112
    • 0036483610 scopus 로고    scopus 로고
    • What does fMRI tell us about neuronal activity?
    • Heeger DJ, Ress D. What does fMRI tell us about neuronal activity? Nat Rev Neurosci 2002;3 2:142-51
    • (2002) Nat Rev Neurosci , vol.3 , Issue.2 , pp. 142-151
    • Heeger, D.J.1    Ress, D.2
  • 113
    • 0025323825 scopus 로고
    • Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system
    • Moseley ME, Cohen Y, Kucharczyk J, Mintorovitch J, Asgari HS, Wendland MF, et al. Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology 1990;176 2:439-45
    • (1990) Radiology , vol.176 , Issue.2 , pp. 439-445
    • Moseley, M.E.1    Cohen, Y.2    Kucharczyk, J.3    Mintorovitch, J.4    Asgari, H.S.5    Wendland, M.F.6
  • 114
    • 0036868662 scopus 로고    scopus 로고
    • Fiber tracking: Principles and strategies - A technical review
    • Mori S, van Zijl PC. Fiber tracking: principles and strategies - a technical review. NMR Biomed 2002;15 7-8:468-80
    • (2002) NMR Biomed , vol.15 , Issue.7-8 , pp. 468-480
    • Mori, S.1    Van Zijl, P.C.2
  • 118
  • 119
    • 0036829477 scopus 로고    scopus 로고
    • Differentiating multiple system atrophy from Parkinson's disease: Contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging
    • Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J Neurol Neurosurg Psychiatry 2002;73 5:517-23
    • (2002) J Neurol Neurosurg Psychiatry , vol.73 , Issue.5 , pp. 517-523
    • Ghaemi, M.1    Hilker, R.2    Rudolf, J.3    Sobesky, J.4    Heiss, W.D.5
  • 120
    • 1842609777 scopus 로고    scopus 로고
    • Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease
    • Schocke MF, Seppi K, Esterhammer R, Kremser C, Mair KJ, Czermak BV, et al. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. NeuroImage 2004;21 4:1443-51
    • (2004) NeuroImage , vol.21 , Issue.4 , pp. 1443-1451
    • Schocke, M.F.1    Seppi, K.2    Esterhammer, R.3    Kremser, C.4    Mair, K.J.5    Czermak, B.V.6
  • 121
    • 1642451932 scopus 로고    scopus 로고
    • Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging
    • Eckert T, Sailer M, Kaufmann J, Schrader C, Peschel T, Bodammer N, et al. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. NeuroImage 2004;21 1:229-35
    • (2004) NeuroImage , vol.21 , Issue.1 , pp. 229-235
    • Eckert, T.1    Sailer, M.2    Kaufmann, J.3    Schrader, C.4    Peschel, T.5    Bodammer, N.6
  • 122
    • 4143085873 scopus 로고    scopus 로고
    • Huntington disease: Volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain
    • Mascalchi M, Lolli F, Della Nave R, Tessa C, Petralli R, Gavazzi C, et al. Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. Radiology 2004;232 3:867-73
    • (2004) Radiology , vol.232 , Issue.3 , pp. 867-873
    • Mascalchi, M.1    Lolli, F.2    Della Nave, R.3    Tessa, C.4    Petralli, R.5    Gavazzi, C.6
  • 124
    • 0027530399 scopus 로고
    • Clinical and magnetic resonance features of the classic and akinetic-rigid variants of Huntington's disease
    • Oliva D, Carella F, Savoiardo M, Strada L, Giovannini P, Testa D, et al. Clinical and magnetic resonance features of the classic and akinetic-rigid variants of Huntington's disease. Arch Neurol 1993;50 1:17-9
    • (1993) Arch Neurol , vol.50 , Issue.1 , pp. 17-19
    • Oliva, D.1    Carella, F.2    Savoiardo, M.3    Strada, L.4    Giovannini, P.5    Testa, D.6
  • 127
    • 0021883670 scopus 로고
    • Regional mitochondrial respiratory activity in Huntington's disease brain
    • Brennan WA Jr, Bird ED, Aprille JR. Regional mitochondrial respiratory activity in Huntington's disease brain. J Neurochem 1985;44 6:1948-50
    • (1985) J Neurochem , vol.44 , Issue.6 , pp. 1948-1950
    • Brennan Jr., W.A.1    Bird, E.D.2    Aprille, J.R.3
  • 129
    • 0029095853 scopus 로고
    • Magnetic resonance image-directed stereotactic neurosurgery: Use of image fusion with computerized tomography to enhance spatial accuracy
    • Alexander E III, Kooy HM, van Herk M, Schwartz M, Barnes PD, Tarbell N, et al. Magnetic resonance image-directed stereotactic neurosurgery: use of image fusion with computerized tomography to enhance spatial accuracy. J Neurosurg 1995;83 2:271-6
    • (1995) J Neurosurg , vol.83 , Issue.2 , pp. 271-276
    • Alexander III, E.1    Kooy, H.M.2    Van Herk, M.3    Schwartz, M.4    Barnes, P.D.5    Tarbell, N.6
  • 130
    • 0242576248 scopus 로고    scopus 로고
    • Stereotactic MR imaging for planning neural transplantation: A reliable technique at 3 Tesla?
    • Donovan T, Fryer TD, Pena A, Watts C, Carpenter TA, Pickard JD. Stereotactic MR imaging for planning neural transplantation: a reliable technique at 3 Tesla? Br J Neurosurg 2003;17 5:443-9
    • (2003) Br J Neurosurg , vol.17 , Issue.5 , pp. 443-449
    • Donovan, T.1    Fryer, T.D.2    Pena, A.3    Watts, C.4    Carpenter, T.A.5    Pickard, J.D.6
  • 131
    • 0026652757 scopus 로고
    • A comparison between magnetic resonance imaging and computed tomography for stereotactic coordinate determination
    • Kondziolka D, Dempsey PK, Lunsford LD, Kestle JR, Dolan EJ, Kanal E, et al. A comparison between magnetic resonance imaging and computed tomography for stereotactic coordinate determination. Neurosurgery 1992;30 3:402-6; discussion 406-407
    • (1992) Neurosurgery , vol.30 , Issue.3 , pp. 402-406
    • Kondziolka, D.1    Dempsey, P.K.2    Lunsford, L.D.3    Kestle, J.R.4    Dolan, E.J.5    Kanal, E.6
  • 132
    • 0343415725 scopus 로고    scopus 로고
    • Accuracy of magnetic resonance imaging stereotactic coordinates with the Cosman-Roberts-Wells frame
    • Carter DA, Parsai EI, Ayyangar KM. Accuracy of magnetic resonance imaging stereotactic coordinates with the Cosman-Roberts-Wells frame. Stereotact Funct Neurosurg 1999;72 1:35-46
    • (1999) Stereotact Funct Neurosurg , vol.72 , Issue.1 , pp. 35-46
    • Carter, D.A.1    Parsai, E.I.2    Ayyangar, K.M.3
  • 133
    • 0345279909 scopus 로고    scopus 로고
    • Activation of neurotransplants in humans
    • Bluml S, Kopyov O, Jacques S, Ross BD. Activation of neurotransplants in humans. Exp Neurol 1999;158 1:121-5
    • (1999) Exp Neurol , vol.158 , Issue.1 , pp. 121-125
    • Bluml, S.1    Kopyov, O.2    Jacques, S.3    Ross, B.D.4
  • 135
    • 16344366522 scopus 로고    scopus 로고
    • Positron emission tomography and single-photon emission computed tomography in central nervous system drug development
    • Brooks DJ. Positron emission tomography and single-photon emission computed tomography in central nervous system drug development. NeuroRx 2005;2 2:226-36
    • (2005) NeuroRx , vol.2 , Issue.2 , pp. 226-236
    • Brooks, D.J.1
  • 136
    • 16544391956 scopus 로고    scopus 로고
    • Oligonucleotides as radiopharmaceuticals
    • Tavitian B. Oligonucleotides as radiopharmaceuticals. Ernst Schering Res Found Workshop 2005;(49):1-34
    • (2005) Ernst Schering Res Found Workshop , Issue.49 , pp. 1-34
    • Tavitian, B.1
  • 138
    • 0033771793 scopus 로고    scopus 로고
    • Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?
    • Goldberg MS, Lansbury PT Jr. Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease? Nat Cell Biol 2000;2 7:E115-9
    • (2000) Nat Cell Biol , vol.2 , Issue.7
    • Goldberg, M.S.1    Lansbury Jr., P.T.2
  • 139
    • 84903202261 scopus 로고    scopus 로고
    • Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease
    • Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P, et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry 2002;10 1:24-35
    • (2002) Am J Geriatr Psychiatry , vol.10 , Issue.1 , pp. 24-35
    • Shoghi-Jadid, K.1    Small, G.W.2    Agdeppa, E.D.3    Kepe, V.4    Ercoli, L.M.5    Siddarth, P.6
  • 140
    • 10744232413 scopus 로고    scopus 로고
    • Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
    • Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004;55 3:306-19
    • (2004) Ann Neurol , vol.55 , Issue.3 , pp. 306-319
    • Klunk, W.E.1    Engler, H.2    Nordberg, A.3    Wang, Y.4    Blomqvist, G.5    Holt, D.P.6
  • 141
    • 4644283049 scopus 로고    scopus 로고
    • PET imaging of amyloid in Alzheimer's disease
    • Nordberg A. PET imaging of amyloid in Alzheimer's disease. Lancet Neurol 2004;3 9:519-27
    • (2004) Lancet Neurol , vol.3 , Issue.9 , pp. 519-527
    • Nordberg, A.1
  • 142
    • 23844456320 scopus 로고    scopus 로고
    • Neuroimaging in Parkinson's disease
    • Brooks DJ. Neuroimaging in Parkinson's disease. NeuroRx 2004;1 2:243-54
    • (2004) NeuroRx , vol.1 , Issue.2 , pp. 243-254
    • Brooks, D.J.1
  • 143
    • 16344381905 scopus 로고    scopus 로고
    • Neuroimaging and therapeutics in movement disorders
    • Eckert T, Eidelberg D. Neuroimaging and therapeutics in movement disorders. NeuroRx 2005;2 2:361-71
    • (2005) NeuroRx , vol.2 , Issue.2 , pp. 361-371
    • Eckert, T.1    Eidelberg, D.2
  • 144
    • 0031595305 scopus 로고    scopus 로고
    • 13C-NMR of glutamate metabolism in the human brain: Initial results at 4 tesla
    • 13C-NMR of glutamate metabolism in the human brain: initial results at 4 tesla. Dev Neurosci 1998;20 4-5:380-8
    • (1998) Dev Neurosci , vol.20 , Issue.4-5 , pp. 380-388
    • Gruetter, R.1    Seaquist, E.R.2    Kim, S.3    Ugurbil, K.4
  • 145
    • 0036522961 scopus 로고    scopus 로고
    • 13C nuclear magnetic resonance spectroscopy: Elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism
    • 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J Neurosci 2002;22 5:1523-31
    • (2002) J Neurosci , vol.22 , Issue.5 , pp. 1523-1531
    • Lebon, V.1    Petersen, K.F.2    Cline, G.W.3    Shen, J.4    Mason, G.F.5    Dufour, S.6
  • 149
    • 2142675181 scopus 로고    scopus 로고
    • Enzymatic assay for perfluoro-tagged metabolites of L-DOPA using crude lysate from E. coli transformed with pKKAADCII
    • Dingman S, Snyder-Leiby T, Mack DJ, Thomas R, Guo C. Enzymatic assay for perfluoro-tagged metabolites of L-DOPA using crude lysate from E. coli transformed with pKKAADCII. Appl Microbiol Biotechnol 2004;64 4:556-9
    • (2004) Appl Microbiol Biotechnol , vol.64 , Issue.4 , pp. 556-559
    • Dingman, S.1    Snyder-Leiby, T.2    Mack, D.J.3    Thomas, R.4    Guo, C.5
  • 150
    • 0038523950 scopus 로고    scopus 로고
    • Endogenous dopamine release after pharmacological challenges in Parkinson's disease
    • Piccini P, Pavese N, Brooks DJ. Endogenous dopamine release after pharmacological challenges in Parkinson's disease. Ann Neurol 2003;53 5:647-53
    • (2003) Ann Neurol , vol.53 , Issue.5 , pp. 647-653
    • Piccini, P.1    Pavese, N.2    Brooks, D.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.